SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories informs about press release

03 Sep 2024 Evaluate
Zenotech Laboratories has informed that the Company has published newspaper advertisements [All editions of Financial Express (in English) and Hyderabad Edition of Nava Telangana (in Telugu)] on September 03, 2024 containing information about 35th Annual General Meeting of the Company and E-Voting. Copies of newspaper clippings are enclosed and also available on the website of the Company at http://zenotechlab.com.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

46.00 -0.90 (-1.92%)
24-Apr-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1625.30
Dr. Reddys Lab 1338.60
Cipla 1300.65
Zydus Lifesciences 931.85
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×